Conversation on Twitter :
Biotech News
@FierceBiotech: Test could detect a range of cancers weeks before symptoms. More | Follow @FierceBiotech
@JohnCFierce: Are clinical trial investigators guilty of mission creep? Report | Follow @JohnCFierce
@RyanMFierce: Maverix enters genomics software game with Silicon Valley sizzle. More | Follow @RyanMFierce
> Shares of MorphoSys AG got a boost after the biotech announced that it would expand its antibody discovery pact with Novartis ($NVS). The financial terms were not disclosed. Story
> Auxilium and Pfizer ($PFE) are wrapping up their EU collaboration on the Dupuytren's treatment Xiaflex, with marketing rights reverting back to Auxilium. Report
> Vectura filed its marketing application for the COPD drug QVA149 in Japan. Story
Pharma News
@FiercePharma: Are you ready, Humira? Pfizer nabs FDA blessing for blockbuster hopeful Xeljanz, for rheumatoid arthritis. Story | Follow @FiercePharma
> Roche's souped-up breast cancer drug steps on FDA fast track. Item
> Obama's re-elected. So what's next for pharma? Story
> Exec says GSK is back on the straight and narrow. Report
@FierceMedDev: BSX study shows improved defibrillator programming reduces unnecessary jolts as well as risk of death. More | Follow @FierceMedDev
@MarkHFierce: BD ended its 2012 fiscal year on a down note. But CE Forlenza qualifies it as a "solid finish." News | Follow @MarkHFierce
@DamianFierce: Medical device manufacturer Onyx got snapped up for $43.25M by Sparton. Story | Follow @DamianFierce
> Mindray tanks on disappointing Q3. Article
> Medtronic-backed study supports greater use of CRT pacemakers. Story
> Study: Valves & stents often win FDA nod without proving they improve care. Item
Drug Delivery News
> Hydrogel time bombs set off explosive drug release. Story
> Novartis submits COPD combination inhaler in Japan. Item
> $1M Gates Foundation grant to formulate lifesaving oxytocin. News
Biomarkers News
> Bowel cancer biomarkers from Down Under catch U.S. attention. Item
> Blood protein tags progression in ALS. Article
> Phase III finding points to masitinib CDx for pancreatic cancer. Story
> Breast cancer biomarkers predict tamoxifen response. Report
> Simple blood count points to survival in aggressive skin cancer. News
And Finally… Investigators say that a protein called SFRP4 in the blood can serve as an efficient biomarker to flag a high risk of diabetes. Release